You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-MAP1B antibody [3G5] - Neuronal Marker (ab3095)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab3095? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab3095 has been referenced in 6 publications.

  1. Hadjivassiliou G et al. The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy. Acta Neuropathol : (2010). IHC-P; Human. PubMed: 20411268
  2. Ahmed Z et al. TACE-induced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin. FASEB J 20:1939-41 (2006). WB; Rat. PubMed: 16849393
  3. Allen E et al. Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature 438:224-8 (2005). PubMed: 16227972
  4. Gong CX et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275:5535-44 (2000). PubMed: 10681533
  5. Edelmann W et al. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proc Natl Acad Sci U S A 93:1270-5 (1996). PubMed: 8577753
  6. Pang Z et al. Neuronal loss and cytoskeletal disruption following intrahippocampal administration of the metabolic inhibitor malonate: lack of protection by MK-801. J Neurochem 66:474-84 (1996). PubMed: 8592116

Publishing research using ab3095? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"